Cart
sales@molnova.com
Poziotinib
CAS No. 1092364-38-9
Poziotinib ( HM781-36B;NOV120101 )
Catalog No. M10347 CAS No. 1092364-38-9
Poziotinib (HM781-36B, NOV120101) is an irreversible pan-HER inhibitor with IC50 of 3.2/5.3 nM/23.5 nM for HER1/HER2/HER4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | In Stock |
|
| 5MG | 81 | In Stock |
|
| 10MG | 105 | In Stock |
|
| 25MG | 243 | In Stock |
|
| 50MG | 372 | In Stock |
|
| 100MG | 554 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePoziotinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionPoziotinib (HM781-36B, NOV120101) is an irreversible pan-HER inhibitor with IC50 of 3.2/5.3 nM/23.5 nM for HER1/HER2/HER4.
-
DescriptionPoziotinib (HM781-36B, NOV120101) is an irreversible pan-HER inhibitor with IC50 of 3.2/5.3 nM/23.5 nM for HER1/HER2/HER4; inhibits phosphorylation of HER family and downstream signaling molecules, and induced apoptosis and G1 arrest; exerts synergistic effects with chemotherapeutic agents.Breast Cancer Phase 2 Clinical
-
SynonymsHM781-36B;NOV120101
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorHER1;HER2;HER4
-
Research AreaCancer
-
IndicationBreast Cancer
Chemical Information
-
CAS Number1092364-38-9
-
Formula Weight491.34
-
Molecular FormulaC23H21Cl2FN4O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC=CC(N1CCC(OC2=CC3=C(NC4=CC=C(Cl)C(Cl)=C4F)N=CN=C3C=C2OC)CC1)=O
-
Chemical Name2-Propen-1-one, 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nam HJ, et al. Cancer Lett. 2011 Mar 28;302(2):155-65.
2. Cha MY, et al. Int J Cancer. 2012 May 15;130(10):2445-54.
3. Kim HJ, et al. Anticancer Drugs. 2012 Mar;23(3):288-97.
2. Cha MY, et al. Int J Cancer. 2012 May 15;130(10):2445-54.
3. Kim HJ, et al. Anticancer Drugs. 2012 Mar;23(3):288-97.
molnova catalog
related products
-
PP2
PP2, a Src family kinase inhibitor, potently inhibits Lck/Fyn with IC50 of 4 nM/5 nM.
-
Ticlopidine
Ticlopidine is an antiplatelet drug in the thienopyridine family which is an adenosine diphosphate (ADP) receptor inhibitor.
-
EGFR-IN-7
EGFR-IN-7 is a selective and potent EGFR kinase inhibitor.TQB3804 displayed potent enzymatic activities for EGFRd746-750/T790M/C797S, EGFRL858R/T790M/C797S, EGFRd746-750/T790M, and EGFRL858R/T790M with IC50 of 0.46, 0.13, 0.26, and 0.19 nM respectively, and has similar enzymatic activity for EGFRWT (IC50 = 1.07) to Osimertinib.
